Active Ingredient History
Lacticaseibacillus casei is an organism that belongs to the largest genus in the family Lactobacillaceae, a lactic acid bacteria (LAB), that was previously classified as Lactobacillus casei. This bacteria has been identified as facultatively anaerobic or microaerophilic, acid-tolerant, non-spore-forming bacteria. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Acute-On-Chronic Liver Failure (Phase 2/Phase 3)
Adenomatous Polyposis Coli (Phase 2)
Allergy and Immunology (Phase 2)
Ascites (Phase 2)
Asthma (Phase 2/Phase 3)
Candidiasis, Vulvovaginal (Phase 3)
Cardiovascular Diseases (Phase 1)
Celiac Disease (Phase 4)
Clostridium Infections (Phase 3)
Colonic Neoplasms (Phase 4)
Colonoscopy (Phase 4)
Constipation (Phase 4)
Coronavirus Infections (Phase 2)
COVID-19 (Phase 2)
Crohn Disease (Phase 4)
Deglutition Disorders (Early Phase 1)
Dental Caries (Phase 2/Phase 3)
Dermatitis, Atopic (Phase 4)
Dermatology (Phase 3)
Diabetes Mellitus (Phase 2)
Diarrhea (Phase 4)
Drug Resistance, Bacterial (Phase 2)
Dyslipidemias (Phase 1/Phase 2)
Dyspepsia (Phase 1/Phase 2)
Eczema (Phase 2/Phase 3)
Esophageal and Gastric Varices (Phase 3)
Fatty Liver (Phase 1)
Fibrosis (Phase 3)
Gastroenteritis (Phase 4)
Gastrointestinal Microbiome (Phase 2)
Healthy Volunteers (Phase 3)
Helicobacter pylori (Phase 4)
Hepatic Encephalopathy (Phase 4)
Hirschsprung Disease (Phase 2)
Hyperlipoproteinemia Type II (Phase 1/Phase 2)
Hypersensitivity (Phase 2/Phase 3)
Immune System Diseases (Phase 3)
Inflammation (Phase 2)
Inflammatory Bowel Diseases (Phase 3)
Interleukin-17 (Phase 1/Phase 2)
Intestinal Neoplasms (Phase 4)
Irritable Bowel Syndrome (Phase 4)
Kidney Failure, Chronic (Phase 2)
Klebsiella pneumoniae (Phase 1/Phase 2)
Lactation (Early Phase 1)
Lactobacillus (Phase 3)
Liver Cirrhosis (Phase 2/Phase 3)
Metabolic Syndrome (Phase 4)
Mothers (Early Phase 1)
Non-alcoholic Fatty Liver Disease (Phase 2)
Obesity (Phase 2/Phase 3)
Osteoporosis (Phase 2)
Peritonitis (Phase 2/Phase 3)
Pneumonia, Viral (Phase 2)
Probiotics (Phase 4)
Purpura, Thrombocytopenic, Idiopathic (Phase 2)
Respiratory Tract Infections (Phase 4)
Rhinitis (Phase 3)
Rhinitis, Allergic (Phase 2)
Rhinitis, Allergic, Perennial (Phase 3)
Signs and Symptoms, Digestive (Phase 2)
Stomatitis, Aphthous (Phase 2)
Vaginosis, Bacterial (Phase 3)
Water Loss, Insensible (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue